PHARMALOGIC HOLDINGS CORP.

Pharmalogic Holdings Corp. specializes in the manufacturing and supply of radiopharmaceuticals for clinical and diagnostic applications, with deep expertise in the production of F-18 labeled compounds such as FDG, Florbetapir (Neuraceq), and PSMA-targeted agents. The company operates as a qualified pharmaceutical preparation manufacturer under NAICS 325412, delivering single-dose, on-demand radiopharmaceuticals that meet strict FDA and NRC regulatory standards for purity, potency, and sterility. Their technical capabilities encompass radiopharmaceutical synthesis, quality control testing, cold kit formulation, and just-in-time logistics for nuclear medicine departments, with demonstrated proficiency in handling short-lived isotopes and maintaining chain-of-custody protocols essential for nuclear healthcare delivery. The contractor maintains a consistent, long-term relationship with the Department of Veterans Affairs, supplying critical radiopharmaceuticals used in oncology, neurology, and cardiology imaging workflows. Their contract history reflects a focus on multi-year ordering periods and recurring clinical needs, indicating a trusted vendor status within VA’s nuclear medicine network. The VA relies on Pharmalogic for reliable, just-in-time delivery of diagnostic agents used in PET imaging, supporting nationwide veteran care initiatives. Pharmalogic’s industry focus is narrowly aligned with pharmaceutical preparation manufacturing, specifically the production of diagnostic radiopharmaceuticals for medical imaging. This positions them as a niche supplier within the nuclear medicine supply chain, serving hospitals and VA facilities requiring FDA-approved, GMP-compliant radiopharmaceuticals with rapid turnaround. Their market role is that of a specialized manufacturer rather than a broad pharmaceutical distributor. As a 2L entity headquartered in Boca Raton, Florida, Pharmalogic Holdings Corp. operates as a small business without federal certifications. Their geographic presence is centered in Florida, but their operational footprint extends nationally through direct delivery to VA medical centers and nuclear pharmacies. They maintain a focused, mission-critical role in supporting the U.S. government’s nuclear diagnostics infrastructure.